#AceHealthReport – Nov.16: The Cambridge-based company said its vaccine appears to be 94.5% effective, according to preliminary data from the company’s still ongoing study. A week ago, competitor Pfizer Inc. announced its own COVID-19 vaccine appeared similarly effective — news that puts both companies on track to seek permission within weeks for emergency use in the U.S:
-
Global Confirmed 54,506,165
-
Global Deaths 1,319,098
-
U.S. Confirmed 11,041,979
-
U.S. Deaths 246,236
- Global Map
U.S. Map
Moderna’s Work on a COVID-19 Vaccine Candidate | Moderna, Inc……. https://www.modernatx.com/modernas-work-potential-vaccine-against-covid-19
Dr. Stephen Hoge, Moderna’s president, welcomed the “really important milestone” but said having similar results from two different companies is what’s most reassuring: ” That should give us all hope that actually a vaccine is going to be able to stop this pandemic and hopefully get us back to our lives,” Hoge told The Associated Press.
” It won’t be Moderna alone that solves this problem: It’s going to require many vaccines” to meet the global demand, he added ”
A vaccine can’t come fast enough, as virus cases topped 11 million in the U.S. over the weekend — 1 million of them recorded in just the past week: The pandemic has killed more than 1.3 million people worldwide, more than 245,000 of them in the U.S: Still, if the Food and Drug Administration allows emergency use of Moderna’s or Pfizer’s candidates, there will be limited, rationed supplies before the end of the year. Both require people to get two shots, several weeks apart
#AceHealthDesk report …………….Published: Nov.16: 2020:
